Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1050)
  3. Book Section (64)
  4. Review (63)
  5. Editorial (38)
  6. Research Letter (37)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2687)
  2. Department of Medicine (2687)
  3. Hematologic Malignancies, Division of (2687)
  4. Population Sciences Research Program (741)
  5. Survivorship Research (651)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (663)
  3. Maria Palomba (440)
  4. Ariela Noy (368)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (34)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (275)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (80)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (291)
  3. Elsevier Inc. (186)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2687)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disappearing signet ring cell adenocarcinoma in gastric cancer patients
    Journal Article

    Sreeram, A.; Stroobant, E. E.; Laszkowska, M.; Guilford, P.; Shimada, S.; Nishimura, M.; Shah, S.; Vardhana, S.; Tang, L. H.; Strong, V. E.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma
    Journal Article

    Benjamini, O.; Fried, S.; Shouval, R.; Flynn, J. R.; Beyar-Katz, O.; Leslie, L. A.; Zuckerman, T.; Yerushalmi, R.; Shem-Tov, N.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy
    Journal Article

    Lamanna, N.; Tam, C. S.; Woyach, J. A.; Alencar, A. J.; Palomba, M. L.; Zinzani, P. L.; Flinn, I. W.; Fakhri, B.; Cohen, J. B.; Kontos, A.; more...
    eJHaem (2024)

    Fulltext@MSK | Save
  • Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
    Journal Article

    Shouval, R.; Goldman, A.; Flynn, J. R.; El-Moghraby, A.; Rehman, M.; Devlin, S. M.; Corona, M.; Landego, I.; Lin, R. J.; Scordo, M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
    Review

    Moskowitz, A. J.; Stuver, R. N.; Horwitz, S. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
    Journal Article

    Krystel-Whittemore, M.; Petrova-Drus, K.; Ptashkin, R. N.; Ewalt, M. D.; Yao, J.; Liu, Y.; Zhu, M.; Benhamida, J.; Durham, B.; Kumar, J.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • What is high-risk mantle cell lymphoma, and how should we treat it?
    Journal Article

    Epstein-Peterson, Z.; Kumar, A.
    Targeted Therapies in Oncology (2024)

    Fulltext@MSK | Save